Superstring Capital Management as of Sept. 30, 2025
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 35 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zai Lab Adr (ZLAB) | 6.7 | $6.8M | 201k | 33.89 | |
| Cidara Therapeutics Com New (CDTX) | 6.5 | $6.6M | 69k | 95.76 | |
| Terns Pharmaceuticals (TERN) | 5.8 | $5.9M | 790k | 7.51 | |
| 89bio (ETNB) | 5.6 | $5.7M | 385k | 14.70 | |
| Immunovant (IMVT) | 5.4 | $5.5M | 341k | 16.12 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.3 | $5.4M | 41k | 131.80 | |
| Cogent Biosciences (COGT) | 5.1 | $5.2M | 361k | 14.36 | |
| Savara (SVRA) | 4.6 | $4.7M | 1.3M | 3.57 | |
| Bridgebio Pharma (BBIO) | 4.5 | $4.6M | 89k | 51.94 | |
| Summit Therapeutics (SMMT) | 4.0 | $4.1M | 197k | 20.66 | |
| Iqvia Holdings (IQV) | 3.6 | $3.6M | 19k | 189.94 | |
| Cabaletta Bio (CABA) | 3.6 | $3.6M | 1.5M | 2.34 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $3.6M | 6.4k | 562.27 | |
| Bright Minds Biosciences Com New (DRUG) | 3.2 | $3.3M | 54k | 60.66 | |
| Nektar Therapeutics Com New (NKTR) | 2.9 | $2.9M | 51k | 56.90 | |
| Insmed Com Par $.01 (INSM) | 2.8 | $2.8M | 20k | 144.01 | |
| Bicara Therapeutics (BCAX) | 2.7 | $2.8M | 176k | 15.79 | |
| Avalo Therapeutics Com New (AVTX) | 2.4 | $2.4M | 188k | 12.71 | |
| Sanofi Sa Sponsored Adr (SNY) | 2.3 | $2.4M | 50k | 47.20 | |
| Zenas Biopharma (ZBIO) | 2.1 | $2.1M | 97k | 22.20 | |
| Uniqure Nv SHS (QURE) | 1.9 | $1.9M | 33k | 58.37 | |
| Tectonic Therapeutic (TECX) | 1.8 | $1.9M | 119k | 15.69 | |
| Urogen Pharma (URGN) | 1.7 | $1.8M | 88k | 19.95 | |
| Protara Therapeutics Com Stk (TARA) | 1.5 | $1.6M | 360k | 4.35 | |
| Keros Therapeutics (KROS) | 1.5 | $1.5M | 95k | 15.82 | |
| Scholar Rock Hldg Corp (SRRK) | 1.4 | $1.5M | 40k | 37.24 | |
| Protagonist Therapeutics (PTGX) | 1.3 | $1.4M | 20k | 66.43 | |
| Travere Therapeutics (TVTX) | 1.3 | $1.3M | 54k | 23.90 | |
| Oric Pharmaceuticals (ORIC) | 1.1 | $1.1M | 89k | 12.00 | |
| Rapt Therapeutics Com New (RAPT) | 0.9 | $888k | 34k | 25.79 | |
| Vir Biotechnology (VIR) | 0.8 | $858k | 150k | 5.71 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.7 | $729k | 58k | 12.65 | |
| I Mab Sponsored Ads (IMAB) | 0.5 | $529k | 140k | 3.78 | |
| Biomea Fusion (BMEA) | 0.5 | $505k | 250k | 2.02 | |
| Century Therapeutics (IPSC) | 0.2 | $231k | 463k | 0.50 |
